Antonella Tramutola

Pubblicazioni

Titolo Pubblicato in Anno
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome NEUROTHERAPEUTICS 2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease MOLECULAR NEUROBIOLOGY 2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease NEUROBIOLOGY OF DISEASE 2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE 2019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome REDOX BIOLOGY 2019
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2019
Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses EXPERT REVIEW OF PROTEOMICS 2019
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models JOURNAL OF ALZHEIMER'S DISEASE 2018
Poly-ubiquitin profile in Alzheimer disease brain NEUROBIOLOGY OF DISEASE 2018
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE 2018
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE 2018
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection FREE RADICAL BIOLOGY & MEDICINE 2018
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies EXPERT REVIEW OF NEUROTHERAPEUTICS 2018
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome TRANSLATIONAL NEURODEGENERATION 2018
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia FREE RADICAL BIOLOGY & MEDICINE 2018
Oxidative stress, protein modification and Alzheimer disease BRAIN RESEARCH BULLETIN 2017
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies EXPERT REVIEW OF NEUROTHERAPEUTICS 2017
Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders FREE RADICAL BIOLOGY & MEDICINE 2017
Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology ANTIOXIDANTS & REDOX SIGNALING 2017
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology EXPERT REVIEW OF NEUROTHERAPEUTICS 2017

ERC

  • LS1_2
  • LS2_8
  • LS5
  • LS5_10
  • LS5_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

My research interests are focused on the study of neurodegenerative processes in Alzheimer Disease and Down syndrome. Our research group has contributed to highlighting the role of increased oxidative stress and dysfunctional protein degradation systems in the pathogenesis and progression of Alzheimer Disease-like dementia in human samples and transgenic murine models. We have demonstrated how the oxidative modification (carbonylation, protein-bound HNE and nitration) of protein involved in proteasome and autophagy functionality are relevant in the progression of the neurodegenerative process.

Keywords

neuroscience
Modulation of Oxidative Stress
autophagy
Down syndrome
Alzheimer disease
brain metabolism

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma